NOVAVAX INC
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $2.77B | $2.83B | $1.57B |
| Jun 2022 | $3.04B | $2.62B | $1.38B |
| Sep 2022 | $2.83B | $2.27B | $1.28B |
| Dec 2022 | $2.89B | $2.26B | $1.34B |
| Mar 2023 | $2.44B | $1.54B | $625.0M |
| Jun 2023 | $2.44B | $1.69B | $505.9M |
| Sep 2023 | $2.34B | $1.66B | $651.1M |
| Dec 2023 | $2.51B | $1.80B | $568.5M |
| Mar 2024 | $2.22B | $1.35B | $480.6M |
| Jun 2024 | $2.25B | $1.82B | $680.2M |
| Sep 2024 | $2.24B | $1.71B | $573.6M |
| Dec 2024 | $2.18B | $1.56B | $530.2M |
| Mar 2025 | $1.37B | $1.29B | $263.3M |
| Jun 2025 | $1.30B | $1.34B | $253.7M |
| Sep 2025 | $1.34B | $1.18B | $268.0M |
| Dec 2025 | $1.30B | $1.18B | $240.6M |
| Mar 2026 | $1.19B | $1.04B | $228.4M |
| Jun 2026 | $1.15B | $955.6M | $191.5M |